![Ben Shepherd](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Ben Shepherd is the founder of Trestle Biotherapeutics, Inc. He held the title of Chief Executive Officer at the company, although he is no longer active in that role.
Actieve functies van Ben Shepherd
Bedrijven | Functie | Begin |
---|---|---|
Trestle Biotherapeutics, Inc.
![]() Trestle Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trestle Biotherapeutics, Inc. is a pre-clinical stage company that develops bioengineered therapies for patients with end-stage renal disease. Trestle Biotherapeutics is based in Encinitas, CA. The company's goal is to create bioengineered stem cell-derived tissues that can replace damaged organs, delay the need for transplantation, and get patients off dialysis. The company was founded by Ben Shepherd and Robert F. Baltera, and Ben Shepherd has been the CEO since incorporation. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Trestle Biotherapeutics, Inc.
![]() Trestle Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Trestle Biotherapeutics, Inc. is a pre-clinical stage company that develops bioengineered therapies for patients with end-stage renal disease. Trestle Biotherapeutics is based in Encinitas, CA. The company's goal is to create bioengineered stem cell-derived tissues that can replace damaged organs, delay the need for transplantation, and get patients off dialysis. The company was founded by Ben Shepherd and Robert F. Baltera, and Ben Shepherd has been the CEO since incorporation. | Commercial Services |